ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

NIH RPG Success Rate to Fall Further

June 7, 2013

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Conference Level For NCI Is 5.4% Over FY 1990

November 2, 1990

Research Base Would Be Increased In Guideline Change

November 9, 1990